All Stories

  1. Hype vs. Health: How Approved Nanomedicines Have Met (or Missed) Early Predictions
  2. Thyreoglobulin
  3. The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment
  4. Development of Co-Amorphous Systems for Inhalation Therapy—Part 2: In Silico Guided Co-Amorphous Rifampicin–Moxifloxacin and –Ethambutol Formulations
  5. Better GRAS than sorry: Excipient toxicity in pulmonary formulations
  6. Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success
  7. Immune Modulation with Nanodiscs: Surface Charge Dictates Cellular Interactions and Activation of Macrophages and Dendritic-like Cells
  8. Skin Sensitization Potential of Sensitizers in the Presence of Metal Oxide Nanoparticles In Vitro
  9. Personalization of lipid-based oral dosage forms via filament-based 3D-printing
  10. Archaeosomes for Oral Drug Delivery: From Continuous Microfluidics Production to Powdered Formulations
  11. Animals in Respiratory Research
  12. Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
  13. Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes
  14. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung
  15. The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
  16. Assessment of Carbon Nanotubes on Barrier Function, Ciliary Beating Frequency and Cytokine Release in In Vitro Models of the Respiratory Tract
  17. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease
  18. Non-Cellular Layers of the Respiratory Tract: Protection against Pathogens and Target for Drug Delivery
  19. Replacement Strategies for Animal Studies in Inhalation Testing
  20. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics
  21. Initial Biological Assessment of Upconversion Nanohybrids
  22. “Biology and Medicine”: A Section of Nanomaterials Addressing Interactions of Nanomaterials with All Forms of Life
  23. Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers
  24. Replacement Strategies for Animal Studies in Inhalation Testing
  25. Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers
  26. Screening for Effects of Inhaled Nanoparticles in Cell Culture Models for Prolonged Exposure
  27. On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
  28. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
  29. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs
  30. Issues with Cancer Spheroid Models in Therapeutic Drug Screening
  31. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients
  32. Impact of drug particle shape on permeability and cellular uptake in the lung
  33. Functional dextran amino acid ester particles derived from N-protected S-trityl-L-cysteine
  34. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles
  35. Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
  36. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View
  37. An automatable platform for genotoxicity testing of nanomaterials based on the fluorometric γ-H2AX assay reveals no genotoxicity of properly surface-shielded cadmium-based quantum dots
  38. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles
  39. The Development of Indicator Cotton Swabs for the Detection of pH in Wounds
  40. Amphiphilic coatings for the protection of upconverting nanoparticles against dissolution in aqueous media
  41. An in vitro and in silico study of the impact of engineered surface modifications on drug detachment from model carriers
  42. Cellular elimination of nanoparticles
  43. Oral uptake of nanoparticles: human relevance and the role of in vitro systems
  44. Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota
  45. MECHANISMS IN ENDOCRINOLOGY: Impact of isolated TSH levels in and out of normal range on different tissues
  46. Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro
  47. In Vitro Assessment of Chronic Nanoparticle Effects on Respiratory Cells
  48. Atomic force microscopy as analytical tool to study physico-mechanical properties of intestinal cells
  49. Intracellular calcium levels as screening tool for nanoparticle toxicity
  50. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
  51. Interactions between nano-TiO2 and the oral cavity: Impact of nanomaterial surface hydrophilicity/hydrophobicity
  52. Chemotherapy and Chemoprevention by Thiazolidinediones
  53. Analogies in the Adverse Immune Effects of Wear Particles, Environmental Particles, and Medicinal Nanoparticles
  54. Use of whole genome expression analysis in the toxicity screening of nanoparticles
  55. The current role of targeted therapies to induce radioiodine uptake in thyroid cancer
  56. The buccal mucosa as a route for TiO2nanoparticle uptake
  57. Photohardening of polymorphic light eruption patients decreases baseline epidermalLangerhans cell density while increasing mast cell numbers in the papillary dermis
  58. Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
  59. Development of an Advanced Intestinal in Vitro Triple Culture Permeability Model To Study Transport of Nanoparticles
  60. Reaction of monocytes to polystyrene and silica nanoparticles in short-term and long-term exposures
  61. Mucus as Barrier for Drug Delivery by Nanoparticles
  62. Mucus as Physiological Barrier to Intracellular Delivery
  63. Gas Permeation, Mechanical Behavior and Cytocompatibility of Ultrathin Pure and Doped Diamond-Like Carbon and Silicon Oxide Films
  64. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
  65. Nano-sized and micro-sized polystyrene particles affect phagocyte function
  66. Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
  67. Titanium dioxide nanoparticles and the oral uptake-route
  68. In Vitro and In Vivo Techniques to Assess Neurotoxicity of Nanoparticles
  69. The oral cavity as a biological barrier system: Design of an advanced buccal in vitro permeability model
  70. Assessment of Long-Term Effects of Nanoparticles in a Microcarrier Cell Culture System
  71. Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols
  72. Suitability of Cell-Based Label-Free Detection for Cytotoxicity Screening of Carbon Nanotubes
  73. New Diagnostic and Therapeutic Tools for Thyroid Cancer
  74. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
  75. In‐Vitro Permeability of Neutral Polystyrene Particles via Buccal Mucosa
  76. Combination of small size and carboxyl functionalisation causes cytotoxicity of short carbon nanotubes
  77. Nanoparticles in Biology and Medicine: Methods and Protocols. Edited by Mikhail Soloviev.
  78. Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies
  79. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties
  80. Differentiation Therapy in Thyroid Carcinoma
  81. Models for oral uptake of nanoparticles in consumer products
  82. Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity
  83. Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
  84. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
  85. Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing
  86. Evaluation of a physiologicalin vitrosystem to study the transport of nanoparticles through the buccal mucosa
  87. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin
  88. Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation
  89. Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines
  90. EP4 receptor stimulation down-regulates human eosinophil function
  91. Targeted High-Throughput Sequencing Identifies Mutations in atlastin-1 as a Cause of Hereditary Sensory Neuropathy Type I
  92. Cholesteryl ester hydrolase activity is abolished in HSL macrophages but unchanged in macrophages lacking KIAA1363
  93. Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target
  94. Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles
  95. Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase
  96. Proliferation analysis of the growth plate after diaphyseal midshaft fracture by 5′-bromo-2′-deoxy-uridine
  97. The Neuron: The Basis for Processing and Propagation of Information in The Nervous System
  98. Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation
  99. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes
  100. Chitosan-4-mercaptobenzoic acid: synthesis and characterization of a novel thiolated chitosan
  101. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C
  102. Chitosan-graft-6-mercaptonicotinic Acid: Synthesis, Characterization, and Biocompatibility
  103. Postpolymerization modification of poly(pentafluorophenyl methacrylate): Synthesis of a diverse water‐soluble polymer library
  104. Efficiency of various dissociation methods for the preparation of thyroid single cell suspensions
  105. The role of nanoparticle size in hemocompatibility
  106. Dipeptidyl peptidase II is not a marker for progression in melanoma
  107. Cytotoxicity of nanoparticles independent from oxidative stress
  108. Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines
  109. Chondrocyte apoptosis enhanced at the growth plate: a physeal response to a diaphyseal fracture
  110. Antitumor Effects of Arsenic Trioxide in Transformed Human Thyroid Cells
  111. Hemocompatibility of various nanoparticles in human blood
  112. Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines
  113. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas
  114. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture
  115. Retinol has specific effects on binding of thyrotrophin to cultured porcine thyrocytes
  116. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  117. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  118. Proteases in malignant tumors
  119. Regional differences and post-mortem stability of enzymatic activities in the retinal pigment epithelium
  120. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
  121. Mammalian Bax triggers apoptotic changes in yeast
  122. Development of multibank rod retinae in deep-sea fishes
  123. Rod Outer Segment Renewal in the Retinae of Deep-sea Fish
  124. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  125. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  126. Patterns of rod proliferation in deep-sea fish retinae
  127. The occurrence of dopaminergic interplexiform cells correlates with the presence of cones in the retinae of fish
  128. Mammalian Müller (glial) cells express functional D2 dopamine receptors